Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Seranova Bio
Seranova Bio

Seranova Bio

Series A

Seranova: An early-stage therapeutics tech company innovating the next generation of treatments.

HQ
South San Francisco, CA, US
Founded
2020
Overview
Compare
Fundraising
Employees

Founded with a mission to revolutionize the field of therapeutics, Seranova Bio is an early-stage company dedicated to developing the next generation of treatments. The company leverages its proprietary REAP technology to explore the role of autoantibodies in disease outcomes, a previously understudied area due to technological constraints. By focusing on these naturally occurring autoantibodies, Seranova aims to unlock new therapeutic potentials and improve patient outcomes.

Seranova Bio has garnered attention for its innovative approach and cutting-edge technology. Though specific notable affiliated people and investors are not detailed, the company's achievements include significant advancements in understanding autoantibodies and their implications for disease treatment. Seranova's impact lies in its potential to transform therapeutic strategies, offering hope for more effective treatments and better health outcomes for patients worldwide.

Seranova Bio - Similar Companies

Santa Ana Bio logo

Santa Ana Bio

santaanabio.com

SeromYx Systems logo

SeromYx Systems

seromyx.com

Serenus Biotherapeutics logo

Serenus Biotherapeutics

Therini Bio logo

Therini Bio

therinibio.com

Juvena Therapeutics logo

Juvena Therapeutics

RenBio logo

RenBio

renbio.com

Regennova logo

Regennova

regennova.com

Locanabio logo

Locanabio

Seneca Therapeutics logo

Seneca Therapeutics

Novoron Bioscience logo

Novoron Bioscience

novoron.com

Dren Bio logo

Dren Bio

drenbio.com

Serotiny logo

Serotiny

serotiny.bio

SanaRx Biotherapeutics logo

SanaRx Biotherapeutics

Septerna logo

Septerna

septerna.com

Seraxis logo

Seraxis

seraxis.com

Seranova Bio - Quick Facts

Who are Seranova Bio's competitors?

Companies similar to Seranova Bio include Santa Ana Bio, SeromYx Systems, Serenus Biotherapeutics and Therini Bio.

When was Seranova Bio founded?

Seranova Bio was founded in 2020.

Where is Seranova Bio's headquarters located?

Seranova Bio's headquarters is located in South San Francisco, CA, US.

When was Seranova Bio's last funding round?

Seranova Bio's most recent funding round was for $5M (USD) in May 2021.

How much has Seranova Bio raised to-date?

As of May 3, 2021, Seranova Bio has raised a total of $5M (USD).

How many employees does Seranova Bio have?

Seranova Bio has 8 employees as of Feb 5, 2024.

Seranova Bio - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified